Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
Mogens Bernsdorf, Christian Ingvar, Leif Jörgensen, Malgorzata K Tuxen, Poul Erik Jakobsen, Anna Saetersdal, Marie Louise Kimper-Karl, Niels Kroman, Eva Balslev, Bent Ejlertsen
55Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial'. Together they form a unique fingerprint.